LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Clinical trial NCT01257477 · COMPLETED

Trial details

NCT number: NCT01257477
Sponsor: Prometheus Laboratories
Status: COMPLETED
Study type: OBSERVATIONAL

Irritable Bowel Syndrome

Start date: 2010-11-01
Primary completion: 2013-03-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.